Search - tctmd.com

Displaying 21 - 40 of 128

Sort: Relevancy | Date

News Conference News ACC 2024

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

Todd Neale

March 27, 2024

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News ACC 2023

Tailored Alerts Up High-Intensity Statin Prescribing: PCDS Statin

Yael L. Maxwell

March 13, 2023

News Conference News ACC 2023

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Michael O'Riordan

March 10, 2023

News Conference News ACC 2023

Wrist-Worn Sensor May Help Detect Elevated Troponin in ACS

L.A. McKeown

March 06, 2023

News Conference News ACC 2023

STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH

Shelley Wood

March 06, 2023

News Conference News ACC 2023

BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF

L.A. McKeown

March 06, 2023

News Conference News ACC 2023

NUDGE-FLU: Emails May Help Increase Flu Vaccination in Elderly

L.A. McKeown

March 05, 2023

News Conference News ACC 2023

COAPT at 5 Years: MitraClip Still Ahead, but Deaths and Crossovers Cast Shadows

Shelley Wood

March 05, 2023

Presentation ACC 2023

Impact of Heart Failure Management Using Thoracic Fluid Monitoring From A Novel Wearable Sensor: Results of the Benefits of Microcor (μCor™) in Ambulatory Heart Failure (BMAD) Trial

Presenter: John P. Boehmer

March 05, 2023

News Conference News ACC 2023

On-site Machine Learning-Based FFRCT Feasible, Informative: TARGET

Caitlin E. Cox

March 04, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Conference News ACC 2022

METEORIC-HF: Omecamtiv Mecarbil Doesn’t Boost Exercise Capacity in HFrEF

Todd Neale

April 08, 2022

News Conference News ACC 2022

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

Michael O'Riordan

April 07, 2022

News Conference News ACC 2022

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

L.A. McKeown

April 07, 2022

News Conference News ACC 2022

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Michael O'Riordan

April 06, 2022

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

L.A. McKeown

April 04, 2022

News Conference News ACC 2022

Most Infected Cardiac Implanted Electronic Devices Not Removed Fast Enough

Michael O'Riordan

April 04, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

Advertisement

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Tailored Alerts Up High-Intensity Statin Prescribing: PCDS Statin

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Wrist-Worn Sensor May Help Detect Elevated Troponin in ACS

STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH

BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF

NUDGE-FLU: Emails May Help Increase Flu Vaccination in Elderly

COAPT at 5 Years: MitraClip Still Ahead, but Deaths and Crossovers Cast Shadows

Impact of Heart Failure Management Using Thoracic Fluid Monitoring From A Novel Wearable Sensor: Results of the Benefits of Microcor (μCor™) in Ambulatory Heart Failure (BMAD) Trial

On-site Machine Learning-Based FFRCT Feasible, Informative: TARGET

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

What’s Going to Be Hot at ACC/WCC 2023?

METEORIC-HF: Omecamtiv Mecarbil Doesn’t Boost Exercise Capacity in HFrEF

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

Most Infected Cardiac Implanted Electronic Devices Not Removed Fast Enough

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content